Vertex Pharmaceuticals Incorporated (FRA:VX1)
369.15
-0.60 (-0.16%)
At close: Oct 23, 2025
Vertex Pharmaceuticals Employees
Vertex Pharmaceuticals had 6,100 employees as of December 31, 2024. The number of employees increased by 700 or 12.96% compared to the previous year.
Employees
6,100
Change (1Y)
700
Growth (1Y)
12.96%
Revenue / Employee
€1,593,952
Profits / Employee
€507,773
Market Cap
93.35B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,100 | 700 | 12.96% |
| Dec 31, 2023 | 5,400 | 600 | 12.50% |
| Dec 31, 2022 | 4,800 | 900 | 23.08% |
| Dec 31, 2021 | 3,900 | 500 | 14.71% |
| Dec 31, 2020 | 3,400 | 400 | 13.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
| Siemens Healthineers AG | 72,000 |
Vertex Pharmaceuticals News
- 18 hours ago - Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference - Business Wire
- 1 day ago - Insiders Bullish on Certain Holdings of JDOC - Nasdaq
- 1 day ago - Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Nasdaq
- 2 days ago - ClearBridge Select Strategy buys REGN, VRTX & VST; exits ICLR, PCTY & ADBE - Seeking Alpha
- 6 days ago - Vertex Pharmaceuticals (VRTX) Advances Povetacicept for Kidney Disease Treatment - GuruFocus
- 6 days ago - Vertex Pharmaceuticals (VRTX) Advances Development of Key Therapeutic - GuruFocus
- 6 days ago - Vertex IgA nephropathy asset povetacicept granted FDA rolling review - Seeking Alpha
- 6 days ago - Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week - Benzinga